Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Immune-mediated neuropathies. Continuum (Minneapolis, Minn.) So, Y. T. 2012; 18 (1): 85-105

Abstract

The immune-mediated neuropathies are an important group of treatable neuropathies that often lead to severe neurologic disability. This review guides clinicians in the recognition and treatment of these disorders.Advances include new insights in classification and new treatment paradigms in many of these disorders.Proper diagnosis and treatment require recognition of the characteristic clinical and laboratory findings and the use of appropriate electrophysiologic or pathologic examination. With proper treatment, partial or complete remission is possible, even in patients who are severely affected.

View details for DOI 10.1212/01.CON.0000411569.72203.9d

View details for PubMedID 22810071